ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 32 filers reported holding ELEVATION ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,064 | -56.4% | 2,312,200 | 0.0% | 0.04% | -58.2% |
| Q2 2023 | $3,514,544 | -20.0% | 2,312,200 | 0.0% | 0.10% | -39.1% |
| Q1 2023 | $4,393,180 | +100.5% | 2,312,200 | 0.0% | 0.16% | +75.0% |
| Q4 2022 | $2,191,272 | -16.1% | 2,312,200 | 0.0% | 0.09% | -14.8% |
| Q3 2022 | $2,613,000 | -19.3% | 2,312,200 | 0.0% | 0.11% | -30.8% |
| Q2 2022 | $3,237,000 | -44.4% | 2,312,200 | +0.0% | 0.16% | -33.0% |
| Q1 2022 | $5,827,000 | -39.9% | 2,312,198 | +43.5% | 0.23% | -33.8% |
| Q4 2021 | $9,702,000 | -21.7% | 1,611,698 | +1.3% | 0.35% | -27.1% |
| Q3 2021 | $12,388,000 | -42.6% | 1,590,298 | +0.0% | 0.48% | -40.3% |
| Q2 2021 | $21,580,000 | – | 1,590,291 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $3,602,616 | 3.79% |
| Aisling Capital Management LP | 2,834,910 | $4,309,063 | 2.11% |
| venBio Partners LLC | 2,914,255 | $4,429,668 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $6,080,000 | 0.90% |
| Velan Capital Investment Management LP | 497,299 | $755,894 | 0.70% |
| Ikarian Capital, LLC | 1,149,490 | $1,747,225 | 0.28% |
| Samsara BioCapital, LLC | 830,565 | $1,262,459 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $1,368,000 | 0.21% |
| DAFNA Capital Management LLC | 450,000 | $684,000 | 0.19% |
| BVF INC/IL | 2,312,200 | $3,514,544 | 0.10% |